Ropinirole Tablet, Film Coated, Extended Release
Product Images NDC 62332-110

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ropinirole (NDC 62332-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ropinirole mg12

This is a packaging label for Ropinirole Extended-Release Tablets, 12 mg strength, film-coated and intended for oral use. The label includes the NDC 62332-111-30 and indicates a quantity of 30 tablets per package. It is manufactured by Alembic Pharmaceuticals Limited and labeled for Alembic Pharmaceuticals Inc. Additional information includes storage instructions and caution about the safety seal.*

FDA Label Image

Ropinirole mg2

Label for Ropinirole Extended-Release Tablets 2 mg, film-coated oral tablets. The label includes dosage strength, NDC 62332-107-30, manufacturer Alembic Pharmaceuticals Inc., directions referencing the pharmacist to dispense an information leaflet, and package size of 30 tablets. Additional details include storage instructions and manufacturing information for Alembic Pharmaceuticals Limited, India.*

FDA Label Image

Ropinirole mg4

Ropinirole Extended-Release Tablets 4 mg by Alembic Pharmaceuticals Inc. This oral tablet is film-coated and supplied in a bottle of 30 tablets. The label includes dosage strength, manufacturing info, NDC 62332-108-30, barcode, and instructions to dispense the patient information leaflet with the medication.*

FDA Label Image

Ropinirole mg6

Ropinirole Extended-Release Tablets, 6 mg strength, film-coated oral tablets. The label indicates a package size of 30 tablets, manufactured by Alembic Pharmaceuticals Inc. The label includes NDC 62332-109-30, dosage details, and storage instructions. It specifies prescription use only and directs pharmacists to dispense the patient information leaflet.*

FDA Label Image

Ropinirole mg8

The label for Ropinirole Extended-Release Tablets 8 mg, film-coated, oral dosage form, manufactured by Alembic Pharmaceuticals Limited. The label displays the product name, strength, NDC 62332-110-30, and indicates a 30-tablet package. It includes storage instructions, manufacturer details, prescription only designation, and a barcode with GTIN and batch information.*

FDA Label Image

Structure (Ropinirole Structure)

Chemical structure diagram of the active ingredient ropinirole, as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.